APOBEC3A and cancer: While we used doxycycline-inducible systems for mechanistic studies, our orthogonal data from cell lines with varying endogenous APOBEC3A levels, TCGA analysis, and DepMap datasets validate these findings in cancers with endogenous APOBEC3A activity, supporting the clinical relevance of the APOBEC3A-TMEJ interaction.